as 05-30-2025 4:00pm EST
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.
Founded: | 1987 | Country: | United States |
Employees: | N/A | City: | CHICAGO |
Market Cap: | 4.1B | IPO Year: | 1991 |
Target Price: | $135.67 | AVG Volume (30 days): | 650.5K |
Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 6.03 | EPS Growth: | 129.73 |
52 Week Low/High: | $62.27 - $140.12 | Next Earning Date: | 05-08-2025 |
Revenue: | $1,741,091,000 | Revenue Growth: | 13.10% |
Revenue Growth (this year): | 13.72% | Revenue Growth (next year): | 6.71% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
MALAFRONTE MICHAEL W | ATGE | Director | Mar 7 '25 | Buy | $87.21 | 1,000 | $87,210.00 | 99,445 |
ATGE Breaking Stock News: Dive into ATGE Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Zacks
2 days ago
Zacks
3 days ago
Zacks
4 days ago
Zacks
4 days ago
Zacks
4 days ago
Zacks
4 days ago
Zacks
9 days ago
The information presented on this page, "ATGE Adtalem Global Education Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.